Premier Research Asia-Pacific Expansion Helps Biotech Advance Life-Changing Therapies
DURHAM, N.C., Sept. 27, 2018 /PRNewswire/ -- Premier Research, a leading provider of clinical development and consulting services to biotech and specialty pharma companies, has again expanded its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan.
The moves increase activities in Australia and New Zealand, where Premier Research has been conducting clinical trials for many years, and also adds to the company's presence in some of the world's fastest-growing biopharmaceutical markets.
Premier Research has conducted a significant number of trials in the Asia-Pacific region. Its enhanced footprint will strengthen the company's reach across these markets and provide greater access to patients, a major benefit to a Contract Research Organization (CRO) engaged in rare disease studies and other research that relies on access to hard-to-find patient populations.
"Our customers are pursuing some of the most elusive treatments to address unmet medical needs," said Ashish Jain, Premier Research Vice President and Head of Asia-Pacific. "Growing our presence in this critical part of the world improves our ability to support our customers as they develop life-changing and life-saving treatments and gives us greater access to the right patients, wherever they live."
Premier Research is a top-ranked CRO for customer service, recipient of a 2018 CRO Leadership Award from Life Science Leader and earning among the highest customer satisfaction ratings in the magazine's latest quality survey. Life Science Leader recognized the company in five of its six award categories: Capabilities, Compatibility, Expertise, Quality, and Reliability. The company has a high rate of repeat business from its customers, 85 percent of which are biotech and specialty pharma companies. Its latest expansion will help the company continue to set the industry standard for innovation and high-touch customer service.
As part of its continuing commitment to serving sponsors in the APAC region, Premier Research will attend two industry conferences in Seoul, South Korea, this fall:
- The KoNECT International Conference, October 31 to November 2.
- Outsourcing in Clinical Trials East Asia, December 5-6.
Contact us with media inquiries or to schedule a meeting at these conferences or another upcoming event.
About Premier Research
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. The company applies a relentless focus on quality in the execution of global, regional, and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical devices, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,300 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that transform breakthrough biotech thinking into reality.
View original content to download multimedia:http://www.prnewswire.com/news-releases/premier-research-asia-pacific-expansion-helps-biotech-advance-life-changing-therapies-300720052.html
SOURCE Premier Research